Best Practices For Designing Patient-Centric Decentralized Clinical Trials

By Jessica Fowler

Decentralized trials, hybrid trials, and agile trials have transformed clinical operations since the advent of COVID-19. Now that our industry has become familiar with flexible design, we’ve noticed the discussion points on these designs continue to stay high-level, relegated to more broad-spectrum adjustments. But at what cost?

The challenge with maintaining a generalized discussion is the difficulty in applying decentralized and hybrid trials to different therapeutic areas. It's crucial to recognize the uniqueness of each clinical trial, much like each patient. Not all elements of decentralized or hybrid designs are universally applicable.

To gain a comprehensive understanding, learn why it's essential to pause, allocate more time for gathering crucial patient feedback, and incorporate it into the planning process.